Indian pharmaceutical giant Aurobindo Pharma Limited expressed strong interest in establishing a manufacturing facility in the Philippines, following a meeting with the Philippine Economic Zone Authority (PEZA) on Sept. 26, 2024.
PEZA, in collaboration with the Food and Drug Administration (FDA), is enhancing its one-stop-shop services to attract pharmaceutical investments.
“Prompt issuance of FDA permits and the planned satellite laboratory demonstrate our commitment to growing the pharmaceutical sector,” said PEZA director-general...
Indian pharmaceutical giant Aurobindo Pharma Limited expressed strong interest in establishing a manufacturing facility in the Philippines, following a meeting with the Philippine Economic Zone Authority (PEZA) on Sept. 26, 2024.
PEZA, in collaboration with the Food and Drug Administration (FDA), is enhancing its one-stop-shop services to attract pharmaceutical investments.
“Prompt issuance of FDA permits and the planned satellite laboratory demonstrate our commitment to growing the pharmaceutical sector,” said PEZA director-general...
Conglomerate Aboitiz Equity Ventures Inc. said Friday its board approved the issuance P12.1-billion worth of fixed-rate bonds.
AEV said in a disclosure to the stock...
SM Investments Corp. topped two award categories in the recent Alpha Southeast Asia magazine awards based on a poll of industry investors.
SM Investments clinched...
